The antagonistic effects of a combination of vancomycin and minocycline in Staphylococcus aureus with heterogeneous resistance to vancomycin

Journal of Infection and Chemotherapy

Volumn 14, Issue 1, 2008, Pages 15-22

  Oshiro, Tomoko ^a   Nagasawa, Zenzo ^b   Hanaki, Hideaki ^c   Ikeda Dantsuji, Yurika ^a   Nagayama, Ariaki ^a  

^a FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAGA UNIVERSITY   (Japan)

^c KITASATO INSTITUTE   (Japan)

Author keywords

Antagonism; Autolytic activity; Minocycline; Lactam induced vancomycin resistant MRSA

Indexed keywords

CHLORAMPHENICOL; LINCOSAMIDE; MACROLIDE; MINOCYCLINE; TETRACYCLINE DERIVATIVE; VANCOMYCIN;

AGAR MEDIUM; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; AUTOLYSIS; BACTERIAL CELL WALL; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIOLYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG ANTAGONISM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORPHOLOGY; NONHUMAN;

EID: 39749173015     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-007-0569-9     Document Type: Article

References (32)

1. K. Hiramatsu N. Aritaka H. Hanaki S. Kawasaki Y. Hosoda S. Hori Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to VCM Lancet 350 1997 1670 1673 10.1016/S0140-6736(97)07324-8
2. I. Haraga S. Nomura A. Nagayama The effects of VCM and β-lactam antibiotics on vancomycin-resistant Staphylococcus aureus N Engl J Med 341 1999 1624 1625 10.1056/NEJM199911183412117
3. C. Liu H.F. Chambers Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods Antimicrob Agents Chemother 47 2003 3040 3045 10.1128/AAC.47.10.3040-3045.2003
4. S. Boyle-Vavra S.K. Berke J.C. Lee R.S. Daum Reversion of the glycopeptide resistance phenotype in Staphylococcus aureus clinical isolates Antimicrob Agents Chemother 44 2000 272 277 10.1128/AAC.44.2.272-277.2000
5. R.F. Pfeltz V.K. Singh J.L. Schmidt M.A. Batten C.S. Baranyk M.J. Nadakavukaren Characterization of passage-selected vancomycin-resistant Staphylococcus aureus strains of diverse parental backgrounds Antimicrob Agents Chemother 44 2000 294 303 10.1128/AAC.44.2.294-303.2000
6. K. Sieradzki T. Leski J. Dick L. Borio A. Tomasz Evolution of a vancomycin-intermediate Staphylococcus aureus strain in vivo: multiple changes in the antibiotic resistance phenotypes of a single lineage of methicillin-resistant Staphylococcus aureus under the impact of antibiotics administered for chemotherapy J Clin Microbiol 41 2003 1687 1693 10.1128/JCM.41.4.1687-1693.2003
7. J. Ariza M. Pujol J. Cabo C. Pena N. Fernadez J. Linares Vancomycin in surgical infections due to methicillin-resistant Staphylococcus aureus with heterogeneous resistance to VCM Lancet 353 1999 1587 1588 10.1016/S0140-6736(99)01017-X
8. P.A. Moise J.J. Schentag Vancomycin treatment failures in Staphylococcus aureus lower respiratory tract infections Int J Antimicrob Agents 16 2000 S31 S34 10.1016/S0924-8579(00)00303-4
9. M.R. Moore F. Perdreau-Remington H.F. Chambers Vancomycin treatment failure associated with heterogeneous vancomycin-intermediate Staphylocococcus aureus in a patient with endocarditis and in the rabbit model of endocarditis Antimicrob Agents Chemother 47 2003 1262 1266 10.1128/AAC.47.4.1262-1266.2003
10. S.S. Wong P.L. Ho P.C. Woo K.Y. Tuen Bacteremia caused by staphylococci with inducible vancomycin heteroresistance Clin Infect Dis 29 1999 760 767 10.1086/520429
11. I. Haraga S. Nomura S. Fukumachi H. Ohjimi H. Hanaki K. Hiramatsu Emergence of vancomycin resistance during therapy against methicillin-resistant Staphylococcus aureus in a burn patient-importance of low-level resistance to vancomycin Int J Infect Dis 6 2002 302 308 10.1016/S1201-9712(02)90165-7
12. R.A. Howe M. Wootton P.M. Bennett A.P. Macgowan T.R. Walsh Interaction between methicillin and vancomycin in methicillin-resistant Staphylococcus aureus strains displaying different phenotypes of vancomycin susceptibility J Clin Microbiol 37 1999 3068 3071
13. N. Aritaka H. Hanaki L. Cui K. Hiramatsu Combination effect of vancomycin and β-lactams against a Staphylococcus aureus strain, Mu3, with heterogeneous resistance to vancomycin Antimicrob Agents Chemother 45 2001 1292 1294 10.1128/AAC.45.4.1292-1294.2001
14. H. Hanaki Y. Yamaguchi S. Nomura I. Haraga A. Nagayama K. Sunakawa Method of detecting β-lactam antibiotic induced vancomycin resistant MRSA (BIVR) Int J Antimicrob Agents 23 2004 1 5 10.1016/j.ijantimicag.2003.05.018
15. M. Sugai T. Akiyama H. Komatsuzawa Y. Miyake H. Suginaka Characterization of sodium dodecyl sulfate-stable Staphylococcus aureus bacteriolytic enzymes by polyacrylamide gel electrophoresis J Bacteriol 172 1999 6494 6498
16. K. Ohta H. Komatsuzawa M. Sugai H. Suginaka Zymographic characterization of Staphylococcus aureus cell wall Microbiol Immunol 42 1998 231 235
17. S. Nomura A. Nagayama Mechanism of enhancement of bactericidal activity of phagocytes against Klebsiella pneumoniae treated with subminimal inhibitory concentrations of cefodizime Chemotherapy 41 1995 267 275 10.1159/000239355
18. W.M. Climo R.L. Patron G.L. Archer Combinations of vancomycin and β-lactams are synergistic against staphylococci with reduced susceptibilities to vancomycin Antimicrob Agents Chemother 43 1999 1747 1753
19. K. Sieradzki R.B. Roberts S.W. Haber A. Tomasz The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection N Engl J Med 340 1999 517 523 10.1056/NEJM199902183400704
20. B.E. Domaracki A.M. Evans R.A. Venezia Vancomycin and oxacillin synergy for methicillin-resistant staphylococci Antimicrob Agents Chemother 44 2000 1394 1396 10.1128/AAC.44.5.1394-1396.2000
21. J.N. Minuth T.M. Holmes D.M. Musher Activity of tetracycline, doxycycline, and minocycline against methicillin-susceptible and resistant staphylococci Antimicrob Agents Chemother 6 1974 411 414
22. K. Takahashi H. Kanno R.M. Chen Effects of combinations of vancomycin with other antibiotics against methicillin-resistant Staphylococcus aureus Jpn J Chemother 34 1986 847 852
23. A. Watanabe Y. Anzai K. Niitsuma M. Saito K. Yanase M. Nakamura Penetration of minocycline hydrochloride into lung tissue and sputum Jpn J Chemother 47 2001 1 9 10.1159/000048494
24. J.R. Torres C.V. Sanders A.C. Lewis Vancomycin concentration in human tissues: preliminary report J Antimicrob Chemother 5 1979 475 477 10.1093/jac/5.4.475
25. K. Niituma M. Saito Vancomycin inhalation therapy – a pharmacokinetic and clinical study of vancomycin Antibiot Chemother 122 1996 123 135
26. S.K. Fridkin J. Hageman L.K. McDougal J. Mohammed W.R. Jarvis T.M. Perl Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997–2001 Clin Infect Dis 36 2003 429 439 10.1086/346207
27. J.L. Koehl A. Muthaiyan R.K. Jayaswal K. Ehlert H. Labischinski B.J. Wilkinson Cell wall composition and decreased autolytic activity and lysostaphin susceptibility of glycopeptide-intermediate Staphylococcus aureus Antimicrob Agents Chemother 48 2004 3749 3757 10.1128/AAC.48.10.3749-3757.2004
28. S. Boyle-Vavra R.B. Carey R.S. Daum Development of vancomycin and lysostaphin resistance in a methicillin-resistant Staphylococcus aureus isolate J Antimicrob Chemother 48 2001 617 625 10.1093/jac/48.5.617
29. K. Sieradzki A. Tomasz Alterations of cell wall structure and metabolism accompany reduced susceptibility to vancomycin in an isogenic series of clinical isolates of Staphylococcus aureus J Bacteriol 185 2003 7103 7110 10.1128/JB.185.24.7103-7110.2003
30. L. Cui X. Ma K. Sato K. Okuma F.C. Tenover E.M. Mamizuka Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus J Clin Microbiol 41 2003 5 14 10.1128/JCM.41.1.5-14.2003
31. H. Hanaki K. Kuwahara-Arai S. Boyle-Vavra R.S. Daum H. Labischinski K. Hiramatsu Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50 J Antimicrob Chemother 42 1998 199 209 10.1093/jac/42.2.199
32. T.L. Smith M.L. Pearson K.R. Wilcox C. Cruz M.V. Lancaster B. Robinson-Dunn Emergence of vancomycin resistance in S taphylococcus aureus N Engl J Med 340 1999 493 501 10.1056/NEJM199902183400701